Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2005. Start Trial.
Date Value
September 30, 2026 92.14%
August 31, 2026 92.14%
July 31, 2026 92.14%
June 30, 2026 92.14%
May 31, 2026 92.14%
April 30, 2026 92.14%
March 31, 2026 92.14%
February 28, 2026 92.14%
January 31, 2026 92.14%
December 31, 2025 92.14%
November 30, 2025 92.14%
October 31, 2025 92.11%
September 30, 2025 92.11%
August 31, 2025 92.11%
July 31, 2025 92.11%
June 30, 2025 92.11%
May 31, 2025 92.11%
April 30, 2025 92.11%
March 31, 2025 92.11%
February 28, 2025 92.11%
January 31, 2025 91.95%
December 31, 2024 91.95%
November 30, 2024 91.30%
October 31, 2024 91.30%
September 30, 2024 91.30%
Date Value
August 31, 2024 91.30%
July 31, 2024 91.30%
June 30, 2024 91.30%
May 31, 2024 91.30%
April 30, 2024 91.30%
March 31, 2024 91.30%
February 29, 2024 91.30%
January 31, 2024 91.30%
December 31, 2023 91.30%
November 30, 2023 91.30%
October 31, 2023 91.30%
September 30, 2023 91.30%
August 31, 2023 91.30%
July 31, 2023 91.30%
June 30, 2023 91.30%
May 31, 2023 91.30%
April 30, 2023 91.30%
March 31, 2023 91.30%
February 28, 2023 91.30%
January 31, 2023 91.30%
December 31, 2022 91.30%
November 30, 2022 91.30%
October 31, 2022 91.30%
September 30, 2022 91.30%
August 31, 2022 91.30%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Lonza Group AG 59.15%
Siegfried Holding AG 93.02%
PolyPeptide Group AG --
Lifecore Biomedical, Inc. 89.19%
Novartis AG 20.42%